Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 55 ($0.71) and traded as high as GBX 56 ($0.73). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.71), with a volume of 70,791 shares trading hands.
Verona Pharma plc (VRP.L) Stock Performance
The stock’s 50-day moving average is GBX 55 and its 200 day moving average is GBX 55. The company has a debt-to-equity ratio of 6.85, a quick ratio of 2.47 and a current ratio of 2.99. The firm has a market cap of £228.00 million and a P/E ratio of -1.68.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Read More
- Five stocks we like better than Verona Pharma plc (VRP.L)
- What is the NASDAQ Stock Exchange?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- Find and Profitably Trade Stocks at 52-Week Lows
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.